Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effect of Dapagliflozin on Cardiac Remodeling in Post Myocardial Infarction Patients

NCT05335629 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05335629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05335629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effect of Dapagliflozin on Cardiac Remodeling in Post Myocardial Infarction Patients
Lead sponsor
Ain Shams University
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2022
Completion date
October 1, 2023
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, myocardial infarction, myocardial remodeling, ventricular